Page last updated: 2024-10-18

imidazole and Colorectal Neoplasms

imidazole has been researched along with Colorectal Neoplasms in 1 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kitagawa, Y1
Okumura, K1
Watanabe, T1
Tsukamoto, K1
Kitano, S1
Nankinzan, R1
Suzuki, T1
Hara, T1
Soda, H1
Denda, T1
Yamaguchi, T1
Nagase, H1

Other Studies

1 other study available for imidazole and Colorectal Neoplasms

ArticleYear
Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment.
    Scientific reports, 2019, 08-05, Volume: 9, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Cell Line, Tumor; Cell-Free Nucleic Acids; Circulating Tumo

2019